Concord Medical Services Holdings Limited (NYSE:CCM) Shares Shorted: Short Interest Down 37.5% in October

Concord Medical Services Holdings Limited (NYSE:CCM) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 6,821 shares, a decline of 37.5% from the September 30th total of 10,916 shares. Approximately 0.3% of the company’s shares are sold short. Based on an average daily trading volume, of 11,855 shares, the short-interest ratio is currently 0.6 days.

Concord Medical Services Stock Performance

CCM opened at $3.75 on Wednesday. The business has a 50 day moving average of $3.84 and a 200-day moving average of $4.19. Concord Medical Services has a 52 week low of $2.79 and a 52 week high of $6.80.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a report on Friday, August 21st. Wall Street Zen raised Concord Medical Services to a “hold” rating in a research note on Saturday, August 15th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Concord Medical Services has a consensus rating of “Sell”.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited was a China-based healthcare services company focused primarily on cancer treatment and diagnostic imaging. The company operated and managed medical facilities that provided radiotherapy, diagnostic imaging, and related oncology services, often through partnerships with hospitals and other healthcare institutions.

Its business also included the provision of medical equipment, technology, and management services to healthcare providers. Concord Medical’s facilities and partnerships were concentrated in China, with a focus on expanding access to specialized cancer diagnosis and treatment in major cities and regional medical centers.

Founded in 2006 and headquartered in Beijing, Concord Medical was historically led by founder and chief executive officer Dr.